Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 42

1.

Salvage Renal Autotransplant Following Previous Renal Vein Stenting in Nutcracker Syndrome.

Al-Qaoud T, Bath N, Redfield R 3rd, Sollinger HW.

Exp Clin Transplant. 2019 May 17. doi: 10.6002/ect.2019.0015. [Epub ahead of print]

2.

APRIL/BLyS blockade reduces donor specific antibodies in allosensitized mice.

Wilson NA, Bath NM, Verhoven BM, Ding X, Boldt BA, Sukhwal A, Zhong W, Panzer SE, Redfield RR 3rd.

Transplantation. 2019 Mar 1. doi: 10.1097/TP.0000000000002686. [Epub ahead of print]

PMID:
30830041
3.

Desensitization and treatment with APRIL/BLyS blockade in rodent kidney transplant model.

Bath NM, Ding X, Wilson NA, Verhoven BM, Boldt BA, Sukhwal A, Reese SR, Panzer SE, Djamali A, Redfield RR 3rd.

PLoS One. 2019 Feb 8;14(2):e0211865. doi: 10.1371/journal.pone.0211865. eCollection 2019.

4.

Attitudes and Perceived Social Norms toward Drug Use among Gay and Bisexual Men in Australia.

Lea T, Hammoud M, Bourne A, Maher L, Jin F, Haire B, Bath N, Grierson J, Prestage G.

Subst Use Misuse. 2019;54(6):944-954. doi: 10.1080/10826084.2018.1552302. Epub 2019 Jan 16.

PMID:
30648480
5.

The "UW-LPHS Test": A New Test to Predict the Outcome of Renal Autotransplant for Loin Pain Hematuria Syndrome.

Sollinger HW, Al-Qaoud T, Bath N, Redfield RR.

Exp Clin Transplant. 2018 Dec;16(6):651-655. doi: 10.6002/ect.2018.0236. Epub 2018 Sep 25.

6.

The Use of Smartphone for Liver Graft Biopsy Assessment at the Time of Procurement.

Bath NM, Wang X, Bledsoe JR, Thijssen M, Ahearn A, Movahedi B, Bozorgzadeh A, Martins PN.

Transplantation. 2018 Nov;102(11):e459-e460. doi: 10.1097/TP.0000000000002389. No abstract available.

PMID:
30080817
7.

Antitumor Activity Associated with Prolonged Persistence of Adoptively Transferred NY-ESO-1 c259T Cells in Synovial Sarcoma.

D'Angelo SP, Melchiori L, Merchant MS, Bernstein D, Glod J, Kaplan R, Grupp S, Tap WD, Chagin K, Binder GK, Basu S, Lowther DE, Wang R, Bath N, Tipping A, Betts G, Ramachandran I, Navenot JM, Zhang H, Wells DK, Van Winkle E, Kari G, Trivedi T, Holdich T, Pandite L, Amado R, Mackall CL.

Cancer Discov. 2018 Aug;8(8):944-957. doi: 10.1158/2159-8290.CD-17-1417. Epub 2018 Jun 11.

PMID:
29891538
8.

Prevalence and correlates of recent injecting drug use among gay and bisexual men in Australia: Results from the FLUX study.

Bui H, Zablotska-Manos I, Hammoud M, Jin F, Lea T, Bourne A, Iversen J, Bath N, Grierson J, Degenhardt L, Prestage G, Maher L.

Int J Drug Policy. 2018 May;55:222-230. doi: 10.1016/j.drugpo.2018.01.018. Epub 2018 Feb 9.

PMID:
29429864
9.

Commentary: Loin Pain Hematuria Syndrome.

Bath NM, Williams DH, Sollinger HW, Redfield RR 3rd.

J Rare Dis Res Treat. 2018;3(4):1-3. doi: 10.29245/2572-9411/2018/4.1169.

10.

Following Lives Undergoing Change (Flux) study: Implementation and baseline prevalence of drug use in an online cohort study of gay and bisexual men in Australia.

Hammoud MA, Jin F, Degenhardt L, Lea T, Maher L, Grierson J, Mackie B, Pastorelli M, Batrouney C, Bath N, Bradley J, Prestage GP.

Int J Drug Policy. 2017 Mar;41:41-50. doi: 10.1016/j.drugpo.2016.11.012. Epub 2017 Jan 9.

PMID:
28081482
11.

Depression, Anxiety, and Stress Among People With Chronic Hepatitis C Virus Infection and a History of Injecting Drug Use in New South Wales, Australia.

Fortier E, Alavi M, Bruneau J, Micallef M, Perram J, Sockalingam S, Dunlop AJ, Balcomb AC, Day CA, Treloar C, Bath N, Haber PS, Dore GJ, Grebely J; ETHOS Study Group.

J Addict Med. 2017 Jan/Feb;11(1):10-18. doi: 10.1097/ADM.0000000000000261.

PMID:
27775955
12.

Treatment for hepatitis C virus infection among people who inject drugs attending opioid substitution treatment and community health clinics: the ETHOS Study.

Grebely J, Alavi M, Micallef M, Dunlop AJ, Balcomb AC, Phung N, Weltman MD, Day CA, Treloar C, Bath N, Haber PS, Dore GJ; ETHOS Study Group.

Addiction. 2016 Feb;111(2):311-9. doi: 10.1111/add.13197. Epub 2015 Nov 25.

PMID:
26451534
13.

Assessment and delivery of treatment for hepatitis C virus infection in an opioid substitution treatment clinic with integrated peer-based support in Newcastle, Australia.

Keats J, Micallef M, Grebely J, Hazelwood S, Everingham H, Shrestha N, Jones T, Bath N, Treloar C, Dore GJ, Dunlop A; ETHOS Study Group.

Int J Drug Policy. 2015 Oct;26(10):999-1006. doi: 10.1016/j.drugpo.2015.07.006. Epub 2015 Jul 17.

PMID:
26275578
14.

Liver disease knowledge and acceptability of non-invasive liver fibrosis assessment among people who inject drugs in the drug and alcohol setting: The LiveRLife Study.

Marshall AD, Micallef M, Erratt A, Telenta J, Treloar C, Everingham H, Jones SC, Bath N, How-Chow D, Byrne J, Harvey P, Dunlop A, Jauncey M, Read P, Collie T, Dore GJ, Grebely J.

Int J Drug Policy. 2015 Oct;26(10):984-91. doi: 10.1016/j.drugpo.2015.07.002. Epub 2015 Jul 16.

PMID:
26256938
15.

The effect of social functioning and living arrangement on treatment intent, specialist assessment and treatment uptake for hepatitis C virus infection among people with a history of injecting drug use: The ETHOS study.

Fortier E, Alavi M, Micallef M, Dunlop AJ, Balcomb AC, Day CA, Treloar C, Bath N, Haber PS, Dore GJ, Bruneau J, Grebely J; ETHOS Study Group.

Int J Drug Policy. 2015 Nov;26(11):1094-102. doi: 10.1016/j.drugpo.2015.06.001. Epub 2015 Jun 11.

PMID:
26145482
16.

Effect of treatment willingness on specialist assessment and treatment uptake for hepatitis C virus infection among people who use drugs: the ETHOS study.

Alavi M, Micallef M, Fortier E, Dunlop AJ, Balcomb AC, Day CA, Treloar C, Bath N, Haber PS, Dore GJ, Grebely J; ETHOS Study Group.

J Viral Hepat. 2015 Nov;22(11):914-25. doi: 10.1111/jvh.12415. Epub 2015 May 21.

PMID:
25996567
17.

Evaluation of two community-controlled peer support services for assessment and treatment of hepatitis C virus infection in opioid substitution treatment clinics: The ETHOS study, Australia.

Treloar C, Rance J, Bath N, Everingham H, Micallef M, Day C, Hazelwood S, Grebely J, Dore GJ.

Int J Drug Policy. 2015 Oct;26(10):992-8. doi: 10.1016/j.drugpo.2015.01.005. Epub 2015 Jan 24.

PMID:
25697089
18.

Investigating the balance of reporting maternal and infant outcomes in pregnancy and childbirth Cochrane reviews.

Starrick E, Bath N, Haas DM.

Am J Perinatol. 2014 Sep;31(8):689-94. doi: 10.1055/s-0033-1357266. Epub 2013 Oct 9.

PMID:
24108666
19.

Peer support models for people with a history of injecting drug use undertaking assessment and treatment for hepatitis C virus infection.

Crawford S, Bath N.

Clin Infect Dis. 2013 Aug;57 Suppl 2:S75-9. doi: 10.1093/cid/cit297. Review.

PMID:
23884070
20.

Assessment and treatment of hepatitis C virus infection among people who inject drugs in the opioid substitution setting: ETHOS study.

Alavi M, Grebely J, Micallef M, Dunlop AJ, Balcomb AC, Day CA, Treloar C, Bath N, Haber PS, Dore GJ; Enhancing Treatment for Hepatitis C in Opioid Substitution Settings (ETHOS) Study Group.

Clin Infect Dis. 2013 Aug;57 Suppl 2:S62-9. doi: 10.1093/cid/cit305.

PMID:
23884068
21.

Injecting drug use among gay and bisexual men in Sydney: prevalence and associations with sexual risk practices and HIV and hepatitis C infection.

Lea T, Mao L, Bath N, Prestage G, Zablotska I, de Wit J, Holt M.

AIDS Behav. 2013 May;17(4):1344-51. doi: 10.1007/s10461-013-0409-0.

PMID:
23321949
22.

Poor uptake of community based sexually transmissible infection testing at an inner city needle and syringe program.

Martin L, Crawford S, Knight V, Bath N, McNulty A.

Sex Health. 2013 May;10(2):183-4. doi: 10.1071/SH12078.

PMID:
23158773
23.

Satisfaction guaranteed? What clients on methadone and buprenorphine think about their treatment.

Madden A, Lea T, Bath N, Winstock AR.

Drug Alcohol Rev. 2008 Nov;27(6):671-8. doi: 10.1080/09595230801935706.

PMID:
19378450
24.

Consumers' and providers' perspectives about consumer participation in drug treatment services: is there support to do more? What are the obstacles?

Bryant J, Saxton M, Madden A, Bath N, Robinson S.

Drug Alcohol Rev. 2008 Mar;27(2):138-44. doi: 10.1080/09595230701829405.

PMID:
18264873
25.

Consumer participation in the planning and delivery of drug treatment services: the current arrangements.

Bryant J, Saxton M, Madden A, Bath N, Robinson S.

Drug Alcohol Rev. 2008 Mar;27(2):130-7. doi: 10.1080/09595230701829397.

PMID:
18264872
26.

Comparison of unsafe drinking between a rural and metropolitan area.

Peach HG, Bath NE, Farish SJ.

Drug Alcohol Rev. 1998 Mar;17(1):117-20.

PMID:
16203475
27.

Modelling hepatitis C virus incidence, prevalence and long-term sequelae in Australia, 2001.

Law MG, Dore GJ, Bath N, Thompson S, Crofts N, Dolan K, Giles W, Gow P, Kaldor J, Loveday S, Powell E, Spencer J, Wodak A.

Int J Epidemiol. 2003 Oct;32(5):717-24.

PMID:
14559738
28.
29.

Comparison of a general practice and hospital placement on medical students' insights into rural practice.

Peach H, Bath N.

Med Teach. 2001 Jan;23(1):102-103. No abstract available.

PMID:
11260755
33.
34.

Prevalence and sociodemographic determinants of cardiovascular risk in a rural area.

Peach HG, Bath NE.

Aust J Rural Health. 1999 Feb;7(1):23-7.

PMID:
10373812
35.

Helicobacter pylori infection is not a correlate of plasma fibrinogen in the Australian population.

Peach HG, Bath NE, Farish SJ.

Clin Lab Haematol. 1999 Feb;21(1):41-3.

PMID:
10197262
36.

Helicobacter pylori infection: an added stressor on iron status of women in the community.

Peach HG, Bath NE, Farish SJ.

Med J Aust. 1998 Aug 17;169(4):188-90.

PMID:
9734575
37.

Predictive value of MCV for hazardous drinking in the community.

Peach HG, Bath NE, Farish S.

Clin Lab Haematol. 1997 Jun;19(2):85-7.

PMID:
9218145
38.

Urologic considerations in Bartter's syndrome.

Dehart HS, Bath NM, Glenn JF, Gunnells JC.

J Urol. 1974 Apr;111(4):420-4. No abstract available.

PMID:
4819361
39.

Labeled polymeric substrate for renin. Synthesis of N-acetyl-poly(L-glutamyl)-( 125 )tridecapeptide and use for enzyme assay.

Bath NM, Gregerman RI.

Biochemistry. 1972 Jul 18;11(15):2845-53. No abstract available.

PMID:
5041900
40.

On the distribution of sodium in the rat portal vein.

B├ąth N, Johansson B, Jonsson O.

Acta Physiol Scand. 1971 Sep;83(1):139-41. No abstract available.

PMID:
5095020
41.

Plasma renin activity in renovascular hypertension.

Bath NM, Gunnells JC Jr, Robinson RR.

Am J Med. 1968 Sep;45(3):381-90. No abstract available.

PMID:
5672737
42.

Prinary aldosteronism.

Gunnells JC Jr, Bath NM, Sode J, Robinson RR.

Arch Intern Med. 1967 Nov;120(5):568-74. No abstract available.

PMID:
6054592

Supplemental Content

Support Center